T. Rowe Price Associates
DFTX

T. Rowe Price Associates’s Definium Therapeutics, Inc. Common Shares DFTX Stock Holding History

T. Rowe Price Associates’s Portfolio DFTX Stock Details DFTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$486K Buy
2025
Q2 		$236K Buy
2025
Q1 		$182K Sell
2024
Q4 		$218K Buy
2024
Q3 		$131K Hold
2024
Q2 		$0 Buy
2022
Q2 		– Sell
2022
Q1 		$33K Buy
2021
Q4 		$32K Sell
2021
Q3 		$67K Buy
2021
Q2 		$96K Buy